Skip to main content
SpringerLink
Log in

Bermuda Triangle: N-terminal pro-B-type natriuretic peptide, stroke, and galectin-3

  • Letter to the Editor
  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chi G, Januzzi JL, Korjian S, Daaboul Y, Goldhaber SZ, Hernandez AF, Hull RD, Gold A, Cohen AT, Harrington RA, Gibson CM (2017) N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy. J Thromb Thrombolysis. doi: 10.1007/s11239-017-1552-7 [Epub ahead of print]

    PubMed  Google Scholar 

  2. Berger WR, Jagu B, van den Berg NWE, Chan Pin Yin DRPP, van Straalen JP, de Boer OJ, Driessen AHG, Neefs J, Krul SPJ, van Boven WP, van der Wal AC, de Groot JR (2017) The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation. Europace. doi:10.1093/europace/eux090 [Epub ahead of print)

    Google Scholar 

  3. King JB, Azadani PN, Suksaranjit P, Bress AP, Witt DM, Han FT, Chelu MG, Silver MA, Biskupiak J, Wilson BD, Morris AK, Kholmovski EG, Marrouche N (2017) Left atrial fibrosis and risk of cerebrovascular and cardiovascular events in patients with atrial fibrillation. J Am Coll Cardiol 70:1311–1321

    Article  PubMed  Google Scholar 

  4. Kocyigit D, Gurses KM, Yalcin MU, Canpinar H, Canpolat U, Evranos B, Yorgun H, Ozer N, Guc D, Aytemir K (2017) Serum galectin-3 level as a marker of thrombogenicity in atrial fibrillation. J Clin Lab Anal. doi:10.1002/jcla.22120 [Epub ahead of print]

    Google Scholar 

  5. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO). Eur Heart J 37:2893–2962

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Near East University, Nicosia, Cyprus

    Levent Cerit

  2. Near East University Hospital, Near East Boulevard, Nicosia, Cyprus

    Levent Cerit

Authors
  1. Levent Cerit
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Levent Cerit.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cerit, L. Bermuda Triangle: N-terminal pro-B-type natriuretic peptide, stroke, and galectin-3. J Thromb Thrombolysis 44, 525–526 (2017). https://doi.org/10.1007/s11239-017-1564-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-017-1564-3

Search

Navigation